HHS Mandates 10% Accessible MDE by July 8, 2026: Legal Exposure Spikes

For healthcare legal teams, the July 8, 2026 deadline represents a critical inflection point. The updated HHS rule not only mandates specific accessibility percentages for medical diagnostic equipment but also cross‑references DOJ Title II requirements, creating overlapping liability risks. Failure to meet the 10% or 20% thresholds could trigger OCR enforcement, private lawsuits, and potential loss of federal funding—outcomes that carry existential threats for covered entities.

Healthcare providers that receive federal funding from the U.S. Department of Health and Human Services (HHS) face a rapidly approaching July 8, 2026 deadline to bring their medical diagnostic equipment (MDE) into compliance with updated accessibility standards under Section 504 of the Rehabilitation Act. This mandate, finalized in 2024, reflects a coordinated push with the U.S. Department of Justice (DOJ), which issued parallel requirements for public entities under Title II of the Americans with Disabilities Act. The rule requires that individuals with disabilities are not denied healthcare services due to inaccessible exam tables, chairs, weight scales, mammography equipment, x-ray machines, and similar devices. For most covered facilities, at least 10% of each type of MDE, but no fewer than one unit, must meet the technical standards that support independent or assisted transfer, proper positioning, and use by those with mobility impairments. Specialty providers focused on conditions affecting mobility, such as rehabilitation and physical therapy centers, are subject to a heightened 20% threshold. Equipment acquired after July 8, 2024 must already conform, and the compliance clock for existing equipment will run out in just days.

“

Failure to meet the 10% or 20% thresholds could trigger OCR enforcement, private lawsuits, and potential loss of federal funding—outcomes that carry existential threats for covered entities.

The regulatory framework stems from a 2024 update to long-standing disability rights protections. Section 504 of the Rehabilitation Act of 1973 prohibits discrimination on the basis of disability in programs receiving federal financial assistance. The new rule operationalizes that prohibition in the context of medical equipment, making explicit that providers cannot cite inaccessible MDE as a reason to delay or deny care. The DOJ’s concurrent rule under Title II ensures that state and local government-run hospitals and clinics face identical obligations. This harmonization aims to create a unified accessibility standard across both federally funded and public healthcare settings, reducing confusion and litigation risk. The HHS rule applies broadly: any entity receiving HHS funding—including through Medicare, Medicaid, CHIP, grants, or other programs—must comply, which captures the overwhelming majority of healthcare providers in the United States.

The operational impact is significant. Providers must audit their existing equipment inventories, determine the percentage of each MDE type that currently meets the standards, and—in many cases—purchase or retrofit equipment. Because the 10% minimum applies per type of equipment, a hospital with 15 examination tables must have at least two accessible units, while a clinic with only one mammography machine must ensure that single unit is accessible. The 20% rule for specialty facilities could require an even larger capital outlay. Financial planners have to weigh immediate compliance costs against the risk of enforcement actions, loss of federal funding, or private litigation. The rule does not provide a grace period for equipment acquired before July 8, 2024; after the July 8, 2026 deadline, all equipment must meet the scoping requirement, regardless of when it was purchased. This creates a hard stop that will test the readiness of many smaller practices and rural health centers with limited budgets.

Enforcement mechanisms remain a concern. HHS’s Office for Civil Rights (OCR) is responsible for investigating complaints and can initiate compliance reviews. Noncompliant providers risk losing federal funding, a potentially existential threat for many institutions. Additionally, private plaintiffs can bring lawsuits under Section 504 and the Americans with Disabilities Act, potentially seeking injunctive relief and monetary damages. The DOJ’s Title II rule adds another layer of exposure for public hospitals and community health centers. Given the high-profile nature of disability rights, watchdog groups and advocacy organizations are likely to monitor compliance closely after the deadline, further increasing the reputational and legal stakes.